A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.
about
Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptorsSynthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose ringsStructure-guided development of heterodimer-selective GPCR ligandsAdenosine amine congener mitigates noise-induced cochlear injuryFunctionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.Molecular modeling of a PAMAM-CGS21680 dendrimer bound to an A2A adenosine receptor homodimer.Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs?Dimerization of G protein-coupled purinergic receptors: increasing the diversity of purinergic receptor signal responses and receptor functions.Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders.Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding.Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes.Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M2R Affinity and Selectivity.
P2860
Q24630178-A544BE67-E16B-4CCA-BAB6-2E61D67A20B9Q28347088-1E57BC53-D817-4677-9E23-DC10CA8C5780Q28828634-8BA96E43-D66E-4DD3-9219-DBE473770EC1Q30479856-D212BCA3-CF39-474D-BA8C-11931D341831Q33926350-C0C98524-99A6-4E2E-950E-6C51D2D0CC49Q34618662-FE6C806B-2CD7-482B-95F5-410727B13A10Q35048339-D91A58D6-79F0-4BC8-A0EC-557535F6D241Q36294009-343C39EE-3918-4BAF-A024-98A292D5B457Q36725267-144C8CDF-0574-4303-9CDD-EA9DABBF6857Q36876553-AEB29821-294C-4DC0-9EFE-B781A9DC8824Q37003068-E98E1DAD-929A-4C3D-BE53-FE546FC2C2C4Q37358680-6930AD12-FEFE-49FC-8011-A5437FAF0A65Q37789040-31836C9D-D05B-41E9-8EF0-6D9F76E0F210Q38066606-AB31C472-40A1-40D0-918C-777BD5958A7DQ38911603-42F75860-ED33-40AD-B4E3-76C3A00C33DEQ42262261-1F9C6566-DE45-41E7-9EE1-384E9F0D78E0Q55710562-45BA777B-13D4-494B-BC53-5C06490C808D
P2860
A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A novel pharmacological approa ...... 3 adenosine receptor agonists.
@ast
A novel pharmacological approa ...... 3 adenosine receptor agonists.
@en
type
label
A novel pharmacological approa ...... 3 adenosine receptor agonists.
@ast
A novel pharmacological approa ...... 3 adenosine receptor agonists.
@en
prefLabel
A novel pharmacological approa ...... 3 adenosine receptor agonists.
@ast
A novel pharmacological approa ...... 3 adenosine receptor agonists.
@en
P2093
P2860
P356
P1476
A novel pharmacological approa ...... 3 adenosine receptor agonists.
@en
P2093
P2860
P304
30272-30279
P356
10.1074/JBC.M001520200
P407
P577
2000-09-01T00:00:00Z